SPWH
Sportsman's Warehouse, a leading outdoor recreation retailer, has announced its Q4 2025 results, exceeding revised expectations despite external pressures. In a conference call on March 31st, CEO Paul Stone and CFO Jennifer Fall Jung shared the company's achievements and strategic progress. The quarter saw a turnaround
NBTX
Nanobiotix, a pioneering biotech company, has made significant strides in the field of oncology, delivering breakthroughs with its Radioenhancer product and new platforms. According to the company's recent conference call transcript, Nanobiotix has been able to move forward in a positive direction with its collaboration with Johnson &
NCNO
nCino, a leading provider of cloud-based banking and financial services platform, has announced its fourth-quarter and fiscal year 2026 earnings, exceeding expectations across key metrics. The company's exceptional performance is attributed to the adoption of its AI strategy and product innovation, with annual contract value (ACV) results seeing
NNDM
Nano Dimension, a leading provider of advanced digital manufacturing solutions, today reported its fourth quarter and full year 2025 earnings, exceeding expectations and positioning the company for growth in key industry segments. According to CEO David Stehlin, the company's performance during the second half of 2025 was marked
LTRN
Lantern Pharma, a leading player in the precision oncology space, has made significant strides in its mission to revolutionize cancer treatment with the power of artificial intelligence (AI). As reported by CEO Panna Sharma during the company's Q4 2025 conference call, Lantern Pharma has achieved clinical validation across
PVLA
Palvella Therapeutics has marked a significant milestone in its journey towards becoming the leading rare disease biopharmaceutical company. In a recent conference call to discuss its full year 2025 financial results, the company highlighted several value-creating milestones achieved during the year. One of the most notable achievements was the announcement
SGMO
Sangamo Therapeutics, a company at the forefront of gene therapy and genomic medicine development, has made significant strides in its pipeline progress despite regulatory and market uncertainty. In its Q4 2025 conference call, the company's executives highlighted several key achievements that underscore its commitment to helping patients in
ZH
On March 25, 2026, Zhihu Inc. announced its fourth quarter and full year 2025 financial results, marking a significant milestone for the company. In 2025, Zhihu achieved its first-ever full-year non-GAAP profit, reaching RMB 37.9 million. This historic achievement validates the company's strategic transformation and underscores the
RANI
Renowned biotech company Rani Therapeutics has made headlines with its stunning fourth-quarter financial results for 2025. The clinical-stage biotherapeutics powerhouse has taken significant strides in advancing and validating the revolutionary Rani Pill platform across multiple therapeutic modalities, while bolstering its financial position and expanding strategic partnerships. As revealed during the
REX
REX American Resources, a leading player in the ethanol industry, has unveiled its exceptional performance in the fourth quarter of fiscal year 2025. The company's latest conference call transcript has revealed a plethora of impressive highlights that have set the stage for sustained growth and success. According to
CGTX
Cognition Therapeutics has announced a significant development shift in its primary therapeutic candidate, zervimesine. In a recent conference call to discuss the company's Q4 2025 earnings, leadership outlined plans to prioritize the treatment of DLB (dementia with Lewy bodies) psychosis over other neurodegenerative disease indications. CEO Lisa Ricciardi
KC
In a bold display of growth and resilience, Kingsoft Cloud has shattered records in the fourth quarter of 2025, announcing a remarkable revenue of RMB 2.76 billion, a staggering 24% year-over-year increase. As reported by Chairman and CEO Tao Zou on the company's recent earnings conference call,